• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)
  • LinkedIn

Stock Screener

Show:

Sort

Country

Sector

Risk rating

1
2
3
4
5
6
7

Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7

Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7

    Results: 65

    ALI HEALTH

    0241.HK
    2

    SINO BIOPHARM

    1177.HK
    5

    KAISA HEALTH

    0876.HK
    2

    SIHUAN PHARM

    0460.HK
    2

    TRAD CHI MED

    0570.HK
    4

    The United Laboratories International Holdings Limited

    3933.HK
    6

    China Resources Pharmaceutical Group Limited

    3320.HK
    6

    Guangdong Hybribio Biotech Co.,Ltd.

    300639.SZ
    2

    SSY Group Limited

    2005.HK
    5

    UNI-BIO GROUP

    0690.HK
    3

    SinoMab BioScience Limited

    3681.HK
    1

    CKLIFE SCIENCES

    0775.HK
    2

    CMS

    0867.HK
    4

    GRAND PHARMA

    0512.HK
    6

    HUTCHMED

    0013.HK
    4

    EXTRAWELL PHAR

    0858.HK
    3

    ELEGANCEOPTICAL

    0907.HK
    1

    Huakang Biomedical Holdings Company Limited

    8622.HK
    1

    Grand Brilliance Group Holdings Limited

    8372.HK
    3

    Regencell Bioscience Holdings Limited

    RGC
    2
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2025